The cervical cancer vaccine, Cervavac, is a Quadrivalent Human Papillomavirus vaccine (qHPV)developed by the Serum Institute of India (SII) and the Department of Biotechnology (DBT).
According to figures from the International Monetary Fund (IMF), India passed the United Kingdom (UK) to become the fifth-largest economy in the world in the last quarter of 2021.